Abstract:Background: The cardiac toxicity of radiotherapy (RT) can affect cancer survival rates over the long term. This has been confirmed in patients with breast cancer and lymphoma. However, there are few studies utilizing the two-dimensional speckle-tracking echocardiography (2D-STE) to evaluate the risk factors affecting radiation induced heart disease (RIHD), and there is a lack of quantitative data. Therefore, we intend to explore the risk factors for RIHD and quantify them using 2D-STE technology. Methods: We ultimately enrolled 40 patients who received RT for thoracic tumors. For each patient, 2D-STE was completed before, during, and after RT and in the follow up. We analyzed the sensitivity of 2D-STE in predicting RIHD and the relationship between RT parameters and cardiac systolic function decline. Results: Left ventricle global longitudinal strain (LVGLS), LVGLS of the endocardium (LVGLS-Endo), LVGLS of the epicardium (LVGLS-Epi), and right ventricle free-wall longitudinal strain (RVFWLS) decreased mid- and post-treatment compared with pre-treatment, whereas traditional parameters such as left ventricular ejection fraction (LVEF), cardiac Tei index (Tei), and peak systolic velocity of the free wall of the tricuspid annulus (s') did not show any changes. The decreases in the LVGLS and LVGLS-Endo values between post- and pre-treatment and the ratios of the decreases to the baseline values were linearly correlated with mean heart dose (MHD) (all P values < 0.05). The decreases in the LVGLS-Epi values between post- and pre-treatment and the ratios of the decreases to the baseline values were linearly correlated with the percentage of heart volume exposed to 5 Gy or more (V5) (P values < 0.05). The decrease in RVFWLS and the ratio of the decrease to the baseline value were linearly related to MHD and patient age (all P values < 0.05). Endpoint events occurred more frequently in the right side of the heart than in the left side. Patients over 56.5 years of age had a greater probability of developing right-heart endpoint events. The same was true for patients with MHD over 20.2 Gy in both the left and right sides of the heart. Conclusions: 2D-STE could detect damages to the heart earlier and more sensitively than conventional echocardiography. MHD is an important prognostic parameter for LV systolic function, and V5 may also be an important prognostic parameter. MHD and age are important prognostic parameters for right ventricle systolic function.

Early Detection of Left Ventricular Dysfunction in Patients with Esophageal Cancer During Concurrent Chemoradiotherapy by Real-Time Three-Dimensional Speckle Tracking Echocardiography

Preliminary Study of Three-Dimensional Speckle Tracking Echocardiography in Evaluation of Left Ventricular Systolic Longitudinal Strain in Patients with Uremia

Assessment of Biventricular Systolic Strain Derived from the Two-Dimensional and Three-Dimensional Speckle Tracking Echocardiography in Lymphoma Patients after Anthracycline Therapy

Evaluation of Left Ventricular Function with Left Atrio-Ventricular Longitudinal Strain in Patients with Lymphoma Underwent Anthracycline Therapy

Three-Dimensional Speckle-Tracking Echocardiography to Evaluate Left Ventricular Function of Patients with Breast Cancer After Anthracycline Chemotherapy

Evaluation of Subclinical Dysfunction of Left Ventricle Induced by Anthracycline in Patients with Lymphoma by ;Two-Dimensional Speckle Tracking Echocardiography and Real-Time Three-Dimensional Echocardiography

Evaluation of the left ventricular myocardial dysfunction in patients with breast cancer after receiving Anthracycline by three-dimensional speckle tracking imaging

Application of two-dimensional speckle-tracking echocardiography in radiotherapy-related cardiac systolic dysfunction and analysis of its risk factors: a prospective cohort study

Evaluation of Subclinical Dysfunction of Left Ventricle Induced by Anthracyclines in Patients with Diffuse Large B-cell Lymphoma by Real-Time Three Dimensional Echocardiography

Early detection of cardiotoxicity by 3D speckle tracking imaging of area strain in breast cancer patients receiving chemotherapy

Three-Dimensional Speckle Tracking Echocardiography for Assessment of Right Ventricular Morphological Changes and Dysfunction on Long-term Lymphoma Survivors Received Anthracycline Therapy

Two-dimensional speckle tracking echocardiography help identify breast cancer therapeutics-related cardiac dysfunction

Difference of left ventricular segmental longitudinal strain in patients with lymphoma receiving anthracycline detected by three dimensional speckle tracking imaging

Anthracycline Induced Inconsistent Left Ventricular Segmental Systolic Function Variation in Patients with Lymphoma Detected by Three-Dimensional Speckle Tracking Imaging

Two-dimensional speckle tracking echocardiography in chemotherapy-induced cardiotoxicity in females with breast cancer

Early detection of immune checkpoint inhibitor-related subclinical cardiotoxicity: A pilot study by using speckle tracking imaging and three-dimensional echocardiography

Prediction of Cardiovascular Adverse Events in Patients Treated with R-CHOP Regimens by 3D Transthoracic Echocardiography

Cardiac Substructures Dosimetric Predictors for Cardiac Toxicity After Definitive Radiotherapy in Esophageal Cancer

Three-Dimensional Speckle Tracking Echocardiography for the Assessment of Left Ventricular Function and Mechanical Dyssynchrony

The Early Variation of Left Ventricular Twisting Function in Patients with Lymphoma Received Anthracycline Therapy Assessed by Three-Dimensional Speckle Tracking Echocardiography.

Early Detection of the Cardiotoxicity Induced by Chemotherapy Drug Through Two-Dimensional Speckle Tracking Echocardiography Combined with High-Sensitive Cardiac Troponin T